Patients with early stage breast cancer may benefit from treatments including surgery and regional radiotherapy, chemotherapy, endocrine therapy, anti-HER2 therapy, and also immunotherapy and cell-based therapies, developed in recent years (2). The gene discussed is ERBB2; the disease is breast carcinoma.